Published in Vaccine Weekly, December 26th, 2001
The properties of vaccinia virus make it a good candidate for use in bladder-directed gene therapies, according to Leonard G. Gomella and colleagues, Thomas Jefferson University, Philadelphia, Pennsylvania.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.